Allogene Therapeutics Announces 2024 Platform Vision to Redefine the Future of CAR T Led by ALPHA3, the Industry s First Pivotal Trial for Frontline Consolidation in Large B-Cell Lymphoma tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Following their discussion on axicabtagene ciloleucel and lisocabtagene maraleucel, panelists reflect on the real-world use of CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma.
Experts Sameh Gaballa, MD, and Matthew Lunning, DO, FACP, share their excitement for an upcoming program centered on the treatment paradigm of relapsed/refractory follicular lymphoma.